Medicine & Life Sciences
Prostatic Neoplasms
100%
Castration
69%
Immunotherapy
59%
Renal Cell Carcinoma
54%
Neoplasms
53%
Nivolumab
45%
T-Lymphocytes
35%
sipuleucel-T
34%
Natural Killer Cells
31%
Leukocytes
28%
Urinary Bladder Neoplasms
25%
Survival
24%
Tumor Microenvironment
24%
Cell Adhesion Molecule-1
24%
Therapeutics
23%
Integrins
23%
Multiparametric Magnetic Resonance Imaging
22%
Anti-Idiotypic Antibodies
20%
Antigens
19%
rucaparib
16%
Chemotactic Factors
16%
Safety
16%
Proteogenomics
16%
TRC105
16%
pazopanib
16%
Ipilimumab
15%
Melanoma
15%
Radiotherapy
15%
Proteomics
14%
Drug Therapy
14%
Carcinoma
13%
Inducible T-Cell Co-Stimulator Protein
13%
Chemokine CCL21
13%
cabozantinib
13%
Neoplasm Metastasis
12%
Progression-Free Survival
12%
Lymphocytes
12%
Axitinib
12%
Central Tolerance
12%
CSK Tyrosine-Protein Kinase
12%
Docetaxel
11%
Chemokines
11%
Noise
11%
Melanoma-Specific Antigens
11%
Dendritic Cells
11%
Biomarkers
11%
Histology
10%
Interleukin-7
10%
Cell-Free Nucleic Acids
10%
tazarotene
10%